No Record Found
Sector
PharmaceuticalsOpen
₹261.65Prev. Close
₹261.65Turnover(Lac.)
₹48.53Day's High
₹261.65Day's Low
₹253.9552 Week's High
₹35552 Week's Low
₹190Book Value
₹118.2Face Value
₹2Mkt Cap (₹ Cr.)
2,357.4P/E
0EPS
0Divi. Yield
0.08No Record Found
| Y/e 31 Mar( In .Cr) | Mar-2025 | Mar-2024 | Mar-2023 | Mar-2022 |
|---|---|---|---|---|
Equity Capital | 18.45 | 18.44 | 18.43 | 18.43 |
Preference Capital | 0 | 0 | 0 | 0 |
Reserves | 1,084.91 | 1,108.18 | 1,008.59 | 885.87 |
Net Worth | 1,103.36 | 1,126.62 | 1,027.02 | 904.3 |
Minority Interest |
| Y/e 31 Mar( In .Cr) | Mar-2021 | Mar-2020 | Mar-2019 | Mar-2018 |
|---|---|---|---|---|
Revenue | 1,240.3 | 1,105.99 | 967.73 | 1,038.21 |
yoy growth (%) | 12.14 | 14.28 | -6.78 | -5.1 |
Raw materials | -354.06 | -330.42 | -320.17 | -346.03 |
As % of sales | 28.54 | 29.87 | 33.08 | 33.32 |
Employee costs | -272.87 | -255.31 | -231.26 | -220.33 |
| Y/e 31 Mar( In .Cr) | Mar-2021 | Mar-2020 | Mar-2019 | Mar-2018 |
|---|---|---|---|---|
Profit before tax | 131.35 | 28.7 | -9.24 | 48.42 |
Depreciation | -73.12 | -70.81 | -71.56 | -67.7 |
Tax paid | -38.95 | -4.46 | 6.4 | -7.23 |
Working capital | 108.84 | 8.53 | -20.15 | -48.05 |
Other operating items |
| Y/e 31 Mar | Mar-2021 | Mar-2020 | Mar-2019 | Mar-2018 |
|---|---|---|---|---|
Growth matrix (%) | ||||
Revenue growth | 12.14 | 14.28 | -6.78 | -5.1 |
Op profit growth | 81.26 | 60.8 | -43.11 | -13.9 |
EBIT growth | 179.41 | 386.57 | -84.29 | -26.21 |
Net profit growth | 281.02 | -953.47 | -106.89 | -46.81 |
| Particulars (Rupees in Crores.) | Mar-2025 | Mar-2024 | Mar-2023 | Mar-2022 | Mar-2021 |
|---|---|---|---|---|---|
Gross Sales | 1,641.29 | 1,788.22 | 1,640.05 | 1,503.73 | 1,218.61 |
Excise Duty | 0 | 0 | 0 | 0 | 0 |
Net Sales | 1,641.29 | 1,788.22 | 1,640.05 | 1,503.73 | 1,218.61 |
Other Operating Income | 23.63 | 29.07 | 28.56 | 37.02 | 22.92 |
Other Income | 6.44 | 21.38 | 2.34 | 2.33 | 3.12 |
Company Name | LTP (₹) | P/E (%) | Mkt.Cap (₹Cr.) | NP Qtr (₹Cr.) | Div.Yield (%) | Sales Qtr (₹.Cr) | Book Value (₹) |
|---|---|---|---|---|---|---|---|
Sun Pharmaceutical Industries Ltd SUNPHARMA | 1,799.5 | 92.3 | 4,31,412.42 | 564.22 | 0.89 | 4,511.27 | 99.24 |
Divis Laboratories Ltd DIVISLAB | 6,417.5 | 67.76 | 1,70,343.22 | 696 | 0.47 | 2,660 | 578.26 |
Torrent Pharmaceuticals Ltd TORNTPHARM | 3,728 | 59.13 | 1,26,185.41 | 597 | 0.16 | 2,707 | 249.83 |
Cipla Ltd CIPLA | 1,516.6 | 23.57 | 1,22,510.62 | 1,210.53 | 1.05 | 4,495.16 | 411.56 |
Dr Reddys Laboratories Ltd DRREDDY | 1,275.2 | 19.73 | 1,06,522.7 | 387.3 | 0.63 | 4,602.9 | 377.56 |
Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.
Chairman & Non Executive Dir.
Suresh G Kare
ED / MD / Promoter
Aditi Kare Panandikar
Joint MD & Executive Director
Sundeep V Bambolkar
Non-Exec & Non-Independent Dir
Anand Nadkarni
Independent Non Exe. Director
Satish Shenoy
Independent Non Exe. Director
Ajay Mulgaokar
Independent Non Exe. Director
Vasudha V Kamat
Independent Non Exe. Director
Abhijit Y Gore
CS / Compliance Officer / Legal Head
RAMANATHAN HARIHARAN
Indoco House 166 C S T Road,
Santacruz (East) Kalina,
Maharashtra - 400098
Tel: 91-022-26541851-55
Website: http://www.indoco.com
Email: compliance.officer@indoco.com
C-101 247 Park,
L B S Marg, Vikhroli West,
Mumbai-400083
Tel: 91-22-49186000
Website: www.linkintime.co.in
Email: paytm.ipo@linkintime.co.in
Summary
Indoco Remedies Limited, incorporated on August 23, 1947 is a Mumbai-based pharmaceutical company focused on formulations, with some presence in contract manufacturing and research. The Company headqu...
Read More
Reports by Indoco Remedies Ltd
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016, BSE Enlistment Number (RA): 5016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor), PFRDA Reg. No. PoP 20092018

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.